These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 14365476)
1. [Effects of x-ray and triethylene melamine in a case of lymphogranulomatosis]. VOSS C Dtsch Med J; 1955 Feb; 6(3-4):103-5. PubMed ID: 14365476 [No Abstract] [Full Text] [Related]
2. [Triethylene melamine therapy of leukemia and lymphogranulomatosis]. MILIC N Lijec Vjesn; 1954; 76(1-2):40-6. PubMed ID: 13175578 [No Abstract] [Full Text] [Related]
3. [Triethylene melamine treatment of leukemia and lymphogranulomatosis]. CAKMAKCI A Turk Tip Cemiy Mecm; 1954 Jun; 20(6):290-314. PubMed ID: 13217043 [No Abstract] [Full Text] [Related]
4. [Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia]. NEUMANN C Klin Wochenschr; 1952 Dec; 30(47-48):1105-8. PubMed ID: 13023980 [No Abstract] [Full Text] [Related]
6. [Treatment of Hodgkin's disease with triethylene melamine; preliminary report]. BOLIO MONSREAL E Bol Liga Contra Cancer Havana; 1953 Jun; 28(3):56-62. PubMed ID: 13115509 [No Abstract] [Full Text] [Related]
7. [Clinical trials with triethylene melamine]. FERRARI M; KASDORF H Arch Urug Med Cir Espec; 1953; 42(3-4):134-44. PubMed ID: 14350952 [No Abstract] [Full Text] [Related]
8. [Therapy of malignant diseases with triethylene melamine]. ROMEO ORBEGOZO JM Rev Clin Esp; 1953 Sep; 50(5):382-6. PubMed ID: 13134813 [No Abstract] [Full Text] [Related]
9. [Clinical experiences with triethylene melamine in therapy of neoplastic diseases of the blood]. BOCK HE; KIRBERGER E; WOELFFER U Z Klin Med; 1953; 150(5):482-98. PubMed ID: 13137291 [No Abstract] [Full Text] [Related]
10. [Effect of TEM on chronic leukemia, lymphogranulomatosis and lymphosarcoma]. HAEHNER E; HEINEN W; LOOSEN H; SCHMIDT H Med Klin; 1954 May; 49(21):853-4; passim. PubMed ID: 13164965 [No Abstract] [Full Text] [Related]
11. Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias. MEZA ARRAU C; NIJAMKIN A Rev Med Chil; 1955 Feb; 83(2):90-5. PubMed ID: 14385308 [No Abstract] [Full Text] [Related]
13. Observations on the use of triethylene melamine in Hodgkin's disease. DE ANDINO AM; ROMERO C; RIVERA J; RODRIGUEZ-MOLINA R Bol Asoc Med P R; 1953 Apr; 45(4):107-18. PubMed ID: 13066528 [No Abstract] [Full Text] [Related]
14. [Triethylene melamine in Hodgkin's disease]. HOST H; QVIGSTAD G Nord Med; 1955 Sep; 54(36):1383-5. PubMed ID: 13266133 [No Abstract] [Full Text] [Related]
15. Triethylene melamine in the treatment of Hodgkin's disease and other lymphomas. ROTTINO A N Y State J Med; 1952 Feb; 52(3):346-8. PubMed ID: 14899689 [No Abstract] [Full Text] [Related]
16. Treatment of lymphomatous diseases with triethylene melamine. MEYER LM; SCHWARTZ SO; SAWITSKY A; BEYERS MR; RITZ ND; BRAHIN C; DIEFENBACH W; KLEINSCHMIDT W; FRIEDMAN I Acta Med Scand Suppl; 1952; 272():1-36. PubMed ID: 13039963 [No Abstract] [Full Text] [Related]
17. [Triethylene melamine therapy of malignant granulomatosis and certain other malignant diseases]. HANSEN PB; BICHEL J Nord Med; 1952 Jan; 47(2):58-61. PubMed ID: 14910945 [No Abstract] [Full Text] [Related]
18. [Diagnosis and therapy of Hodgkin's disease; study of 110 cases]. JUSTIN-BESANCON L; LAMOTTE-BARRILLON S; DEBRAY J Sem Hop; 1952 Dec; 28(95):3855-71. PubMed ID: 13048712 [No Abstract] [Full Text] [Related]
19. [Treatment of hemoblastosis with triethylene melamine]. LINKE A; LASCH HG Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032 [No Abstract] [Full Text] [Related]